NVE (NVEC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
19 Jul, 2026Technology and innovation
Specializes in spintronics, leveraging electron spin for information processing and storage.
Devices feature nanoscale critical dimensions as small as 3.5 nm.
Holds over 50 issued U.S. patents and more than 100 patents issued, pending, or licensed.
Expanded its unique spintronics factory in 2026 to support growth.
Market presence and applications
Products are integrated into medical devices, IoT/AIoT, robotics, and power conversion.
Focuses on miniaturization and power efficiency, with chip-scale packaging.
Devices are recognized for reliability, low power consumption, and AIoT connectivity.
Serves world-class customers and maintains strong partnerships.
Financial performance and strategy
Achieved gross profit margin of 79%, operating margin of 60%, pretax margin of 68%, and net margin of 58% for YE 3/31/26.
Operating margin ranks in the top percentile among semiconductor companies.
Invested $3.4 million in capital expenditures over the past two years to expand capacity.
Maintains a strong balance sheet with $43.5 million in cash and marketable securities and $58.2 million in shareholders' equity as of 3/31/26.
Latest events from NVE
- Revenue and net income soared over 79% year-over-year, with a $1.00 dividend declared.NVEC
Q1 202722 Jul 2026 - Q3 revenue up 23% to $6.22M, net income up 11%, and a $1.00 dividend declared.NVEC
Q3 20268 Jul 2026 - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.NVEC
Proxy filing22 Jun 2026 - Shareholders will vote on directors, executive pay, and auditor ratification at the 2026 meeting.NVEC
Proxy filing22 Jun 2026 - Leadership transitions and robust growth mark a year of expansion and innovation.NVEC
Proxy filing22 Jun 2026 - Board expansion, executive pay, and auditor ratification headline the August 2026 proxy.NVEC
Proxy filing22 Jun 2026 - Quarterly net income rose 27% year-over-year, driven by strong product sales and margin gains.NVEC
Q4 20267 May 2026 - Revenue and net income declined, but gross margin and cash returns to shareholders remained strong.NVEC
Q1 20253 Feb 2026 - Gross margin rose to 86% as R&D revenue surged and a $1.00 dividend was declared.NVEC
Q2 202519 Jan 2026